Asia-Pacific Biologics and Biosimilars Market Analysis 2012-2017 and Forecast 2018-2023

ReportPage
Report ID
26432
Published Date
14-Mar
No of Report Page
113
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details

    Snapshot
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimil

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 Biologics and Biosimilars Industry
    1.1.1 Overview
    1.1.2 Development of Biologics and Biosimilars
    1.2 Market Segment
    1.2.1 By Product Type
    1.2.2 By Application
    1.3 Asia-Pacific Overview
    2 Major Companies List
    2.1 Roche (Company Profile, Products & Services, Sales Data etc.)
    2.2 Amgen (Company Profile, Produ

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample